Tuberculosis drug development pipeline: progress and hope
More than 50 years after the introduction of effective chemotherapy for tuberculosis, the disease remains unconquered and in many resource-poor
More than 50 years after the introduction of effective chemotherapy for tuberculosis, the disease remains unconquered and in many resource-poor
Morning Edition 11:00 AM EST ANCHORS: STEVE INSKEEP REPORTERS: BRENDA WILSON HOST: STEVE INSKEEP One-third of the world’s population is
Three Grants Announced at Columbia University Symposium Tracking Progress in Battle Against Disease Infecting One-Third of the World NEW YORK
LONDON (Reuters) – The governments of Britain, the Netherlands and Ireland said on Tuesday they were giving $14.2 million (8
Project Aims to Streamline and Shorten Drug Development for Tuberculosis New York, NY and Waltham, MA., February 21, 2006 –
For the first time in decades, pharma has tuberculosis drugs in the pipeline. But it will take more than new
An international partnership yesterday laid out a plan to treat 50 million people with tuberculosis and save 14 million lives
Pursuing drugs for neglected diseases is not a traditional part of the pharmaceutical company portfolio. But Paul Herrling of Novartis
An array of well-heeled new players has dramatically reshaped how wealthy countries tackle infectious diseases of the poor. But increasingly,
At its October 2005 Board Meeting, the TB Alliance Board of Directors appointed two new Board members to three-year terms: